Pfizer | PFE - Frais De Vente Et D'Administration

Prix De L'Action
27.00
Variation Quotidienne
0.33 1.24%
Mensuellement
-1.03%
Annuel
17.80%
Q2 Prévisions
26.42




Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.89B 325M 2025-12
Abbott USD 3.27B 138M 2026-03
ALKERMES USD 187.2M 15.43M 2025-12
Amgen USD 1.94B 237M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Bayer EUR 4.05B 647M 2025-12
Biogen USD 545.2M 38.6M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Coherus Biosciences USD 15M 6.26M 2025-12
Drreddys Laboratories INR 26.92B 3.74B 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Glaxosmithkline GBP 3.56B 650.29M 2025-12
J&J USD 6.03B 719M 2026-03
Medtronic 2.97B 159M 2025-09
Merck USD 2.85B 215M 2025-12
Neurocrine Biosciences USD 301.8M 10.2M 2025-12
Novartis USD 3.44B 128M 2025-12
Novartis USD 3.44B 132M 2025-12
Pacira USD 91.87M 70K 2025-12
Perrigo USD 255.9M 10.2M 2025-12
Pfizer USD 4.08B 894M 2025-12
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 29.67M 1.64M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.33B 419M 2026-03
Sanofi EUR 2.75B 455M 2025-12
Vertex Pharmaceuticals USD 487M 41.9M 2025-12
Zoetis USD 619M 40M 2025-12